Growing global real-world and clinical data


WHILE Pfizer, BioNTech and Johnson & Johnson have raised the strong probability for the need of an extra dose of vaccine to provide enough immunity against Covid-19 variants, AstraZeneca says it is not yet sure whether a booster dose of its vaccine will be necessary for continued protection against the coronavirus.

As AstraZeneca CEO Pascal Soriot explained on news channel CNBC recently, “There are two dimensions to this immunity – antibodies [which] decline over time, but the second, very important dimension of vaccination is the so-called T-cells. They tend to protect people against severe disease, but they also provide durability.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Focus

Ukraine’s trains keep rolling on
Riding into the past
Trump meets defeat with mayhem
Fruit of the absurd
South-East Asia risks slipping down Washington’s agenda
Major US foreign policy shifts unlikely before 2028
Loss might ‘tone down’ Trump
A whale of a blue wave
Peace is good politics
Sex, spies and cyberchips

Air Pollutant Index

Note: API is calculated based on 24hr running average of the most dominant parameter.

Highest API Readings

    Select State and Location to view the latest API reading

    Others Also Read